kabutan

TERUMO CORPORATION(4543) Summary

4543
TSE Prime
TERUMO CORPORATION
1,997.0
JPY
-24.5
(-1.21%)
Jan 29, 3:07 pm JST
13.04
USD
Jan 29, 1:07 am EST
Result
PTS
outside of trading hours
1,996.8
Jan 29, 3:06 pm JST
Summary Chart Historical News Financial Result
PER
21.6
PBR
2.05
Yield
1.50%
Margin Trading Ratio
1.25
Stock Price
Jan 29, 2026
Opening Jan 29, 9:00 am
1,998.0 JPY 13.04 USD
Previous Close Jan 28
2,021.5 JPY 13.24 USD
High Jan 29, 9:57 am
2,019.5 JPY 13.20 USD
Low Jan 29, 9:06 am
1,975.0 JPY 12.90 USD
Volume
5,298,200
Trading Value
0.01T JPY 0.07B USD
VWAP
2001.56 JPY 13.07 USD
Minimum Trading Value
199,700 JPY 1,304 USD
Market Cap
2.96T JPY 0.02T USD
Number of Trades
9,967
Liquidity & Number of Trades
As of Jan 29, 2026
Liquidity
High
1-Year Average
6,485
1-Year High Apr 7, 2025
26,620
Margin Trading
Date Short Interest Long Margin Positions Ratio
Jan 23, 2026 185,100 2,023,200 10.93
Jan 16, 2026 166,800 1,494,200 8.96
Jan 9, 2026 207,300 1,151,000 5.55
Dec 26, 2025 204,000 882,600 4.33
Dec 19, 2025 200,500 945,800 4.72
Company Profile
TERUMO CORPORATION is a leading manufacturer of medical devices, with a strong presence in the cardiovascular field. The company holds a high global market share in catheters and heart-lung machines.
Sector
Precision Instruments
TERUMO CORPORATION is a major medical device manufacturer with its business divided into three segments: "Cardiac and Vascular Company," "Medical Care Solutions Company," and "Blood and Cell Technologies Company." The group consists of numerous consolidated subsidiaries and equity-method affiliates, operating globally with an overseas sales ratio approaching 80%. The company offers a wide range of products across various business fields, with a particular strength in cardiovascular care, providing comprehensive solutions to meet the needs of medical professionals.